Noble Pharma formulates and manufactures oral and topical animal health pharmaceutical products.
Founded in 2018 and based in Menomonie, US, Noble Pharma manufactures animal health products in forms including chews, creams, ointments, suspensions, tablets, powders and pastes. It provides formulation, development and manufacturing services, with quality control, analytical and microbiology laboratories and stability testing. In January 2022, DW Healthcare Partners invested in the company. It planned to use the funds to expand capabilities and operations and accelerate product commercialization.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in